Published June 2009 | Version v1
Report

Analysis of proteome change before and after carbon ion radiotherapy of non small-cell lung cancer

  • 1. National Inst. of Radiological Sciences, Chiba, Chiba (Japan)
  • 2. Chiba Univ., Graduate School of Medicine, Chiba, Chiba (Japan)

Description

Carbon ion radiotherapy (CIRT) for non-small cell lung cancer (NSCLC) is an effective and low invasive therapy with an excellent local control rate but there have been few histopathologic observations about the effect of CIRT on the human body. In this study, we aimed to explore peptides that reflect the effect of CIRT on NSCLC with matrix-assisted laser desorption/ionization time-of-flight mass spectrometly (MALDI-TOF MS) serum profiling. We enrolled 36 NSCLC patients who underwent CIRT in our hospital from September, 2006 to February, 2008. Serum samples were collected from these patients before treatment and 1 day and 1, 3, 6 months after treatment. We then prepared 5 μL of serum with magnetic beads and profiled serum proteome using MALDI-TOF MS. Nine peaks showed significant changes before and after treatment. We identified the 2861 Da peak as a fibrinogen alpha chain fragment. The 2861 Da peptide was upregulated soon after irradiation and then declined immediately, and this change was dependent on the dose per fraction. Additionally, 5890 Da and 7738 Da peak are likely to be the peptides which we had identified in our former study. These peaks changed gradually soon after irradiation. These serum peptides were considered to reflect the vital reaction and treatment effect after CIRT. (author)

Part of:
2008 Annual report of the research project with heavy ions at NIRS-HIMAC

Additional details

Publishing Information

Imprint Title
2008 Annual report of the research project with heavy ions at NIRS-HIMAC
Imprint Pagination
349 p.
Journal Page Range
p. 7-8
Report number
NIRS-M--226

Optional Information

Notes
This record replaces 44074414